SARS-CoV-2 Spike Protein-Directed Monoclonal Antibodies May Ameliorate COVID-19 Complications in APECED Patients

Overview of attention for article published in Frontiers in immunology, August 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

So far, Altmetric has seen 34 X posts from 27 X users, with an upper bound of 165,646 followers.

@SherryLyn369 Here's why Covid is triggering so many various issues and why antifungal treatments work. https://t.co/bNEqcfGwgb https://t.co/fXfHfR3oU4

SARS-CoV-2 Spike Protein-Directed Monoclonal Antibodies May Ameliorate COVID-19 Complications in APECED Patients https://t.co/SBVsuZFTGD

RT @LionakisLab: APS-1/APECED patients harbor type-I IFN Aabs and have inflammation-prone lung tissue, thus carrying a high risk for severe…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 30 additional X posts.